Chronic Myeloid Leukemia Panel - Disclosures
|
Panel Member
|
Jessica Altman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Maria Amaya MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kebede Begna MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ellin Berman MD |
|
Grant/Research Support
|
| Novartis Pharmaceuticals Corporation |
|
Date Completed
|
08/26/2024 |
|
Panel Member
|
Ravi Bhatia MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Onyee Chan MD |
|
Grant/Research Support
|
| AbbVie, Inc. | Jazz Pharmaceuticals Inc. |
|
Date Completed
|
07/08/2024 |
|
Panel Member
|
Joan Clements |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Robert Collins MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Peter Curtin MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Magdalena Czader MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel DeAngelo MD, PhD |
|
Grant/Research Support
|
| AbbVie, Inc. | Blueprint Medicines | Cogent | GlycoMimetics, Inc. |
|
Date Completed
|
03/24/2025 |
|
Panel Member
|
Michael Drazer MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tanya Fischer MEd, MLIS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ximena Jordan Bruno MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ann Karosas RPh, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lori Maness MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Leland Metheny MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sanjay Mohan MD, MSCI |
|
Grant/Research Support
|
| Incyte Corporation | Kartos | Karyopharm Therapeutics | Taiho Pharmaceuticals Co., Ltd. |
|
Date Completed
|
03/06/2025 |
|
Panel Member
|
Javid Moslehi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vivian Oehler MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Iskra Pusic MD, MSCI |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lindsay Rein MD |
|
Grant/Research Support
|
| Blueprint Medicines | Cogent | Geron | Incyte Corporation | Karyopharm Therapeutics | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | PharmaEssentia | Protagonist | Sumitomo Dainippon Pharma | Telios |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
Michal Rose MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Koji Sasaki MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Neil Shah MD, PhD |
|
Grant/Research Support
|
| Bristol Myers Squibb |
|
Date Completed
|
08/20/2024 |
|
Panel Member
|
William Shomali MD |
|
Grant/Research Support
|
| Blueprint Medicines | Incyte Corporation |
|
Date Completed
|
07/30/2024 |
|
Panel Member
|
B. Douglas Smith MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael Styler MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Hema Sundar PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bettyanne Sunderland BSN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Moshe Talpaz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tiffany Tanaka MD |
|
Grant/Research Support
|
| Function Oncology |
|
Date Completed
|
10/11/2024 |
|
Panel Member
|
Srinivas Tantravahi MBBS, MRCP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
James Thompson MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Steven Tsai MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jennifer Vaughn MD, MSPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jeanna Welborn MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Yang MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
